Coexistence of myelodysplastic syndrome and multiple myeloma

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 4, 1999, Pages 565-566

  Tsiara, St ^a   Economou, G ^a   Panteli, A ^a   Isaakidis, P ^a   Kapsali, E ^a   Bourantas, K L ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Dept of Int Medicine Hematology ^*  (Greece)

Author keywords

Multiple myeloma; Myelodysplastic syndrome

Indexed keywords

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; EPISTAXIS; HUMAN; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MULTIPLE MYELOMA;

EID: 0033493026     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jeha M.T., Hamblin T.J., Smith J.L.: Coincident chronic lymphocytic leukemia and osteosclerotic multiple myeloma. Blood, 57: 617-619, 1981.
2. Quesenberry P., Levitt L.: Hemopoietic stem cells. N. Engl. J. Med. 301: 755-760, 1979.
3. Tanaka M., Kimura R., Matsutani A., Zaitsu K., Oka Y., Oizumi K.: Coexistence of chronic myelogenous leukemia and multiple myeloma. Acta Haematol. 99: 221-223, 1998.
4. Soeuen V., Prendhomme C., Roumier C., Lai G.L., Leplelly P., FAcon T., Pagniez D., Fenaux P.: Myelodyssplasia during the course of myeloma. Restriction of 17p deletion and p53 over expression to myeloid cells. Leukemia 12: 238-241, 1988.
5. Lai J.L., Prendhomme C., Zendecki M., Elactif M., Vanrumbeke M., Wattel E., Fenaux P.: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion: an entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia 9: 370-381, 1995.
6. Buckman R., Cuzick J., Galton DAG: Long-term survival in myelomatosis. Br. J., Haematol. 52: 589-599, 1982.
7. Cuzick J., Erskine S., Edelman D., Galton DAG: A comarison of the incidence of myelodysplastic syndrome and acute myelodi leukemia following melphalan and cyclophosphamide treatment for myelomatosis. Br. J. C ancer 55: 523-529, 1987.
8. Mufti G.J., Hamblin T.J., Clein G.P., Race C.: Coexistent myelodysplasia and plasma cell neoplasia. Br. J. Haematol. 54: 91-96, 1983.
9. Bergsagel D.E.: Plasma cell neoplasms and acute leukemia. Clin. Haematol. 11: 221-234, 1982.
10. Rosner F., Grunwald H.W.: Simultaneous occurrences of multiple myeloma and acute myeloblastic leukemia:d fact or myth? Am. J. Med. 76: 891-899, 1984.
11. Bergsagel D.E.: Plasma cell neoplasms and acute leukemia. Clin. haematol. 11: 221-234, 1982.
12. Coleman C.N., Williams C.J., Flint A.: Hematologic neoplasia in patients treated for Hodgkin's disease. N. Engl. J. Med. 297: 1249-1252, 1977.
13. Ritzman S.E., Stoufflet E.J., Houston E.W., Levin W.C.: Coexistent chronic myelocytic leukemia, monoclonal gammopathy and multiple chromosomal abnormalities. Am. J. Med. 41: 981-989, 1966.
14. Barlogie B., Epstein J., Salvanayagom P., Alexaniar R.: Plasma cell myeloma. New biological insights and advances in therapy. Blood 73: 865-879, 1989.